Antoine Barouky  is the interim Deputy CEO of Valerio Therapeutics and Venture Partner at Invus since 2023, working closely with the public and private healthcare teams across geographies.

Prior to joining Invus, Antoine was a founding member of the executive teams of several US-based companies in Europe, including Alnylam, Shire, Cubist, and Forest Laboratories, where he built and led operations for thirteen years. Earlier in his career, he held various leadership positions at Stallergenes over twelve years, including Senior Vice President of Business and Corporate Development.

Antoine holds a Master’s degree in Biotechnology Engineering from the Institut National des Sciences Appliquées de Lyon and a Master’s in Finance from HEC Paris.

Antoine Barouky was appointed as interim CEO of Valerio Therapeutics on February 20, 2025.